Molecular mass: 290.906 g/mol PubChem compound: 123801
Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09BA01 | Technetium (99mTc) oxidronic acid | V Various → V09 Diagnostic radiopharmaceuticals → V09B Skeleton → V09BA Technetium (99mTc) compounds |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| TECHNESCAN HDP Powder for solution | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Technetium ⁹⁹ᵐTc oxidronic acid is an active ingredient of these brands:
United States (US)
Austria (AT)
Estonia (EE)
France (FR)
Hong Kong (HK)
Ireland (IE)
Malta (MT)
Romania (RO)
Singapore (SG)
Spain (ES)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
